上半年共查办医疗违法案件1666件

Core Viewpoint - The National Market Regulation Administration has intensified its regulatory efforts on medical advertising, particularly targeting fraudulent "miracle doctor" ads, and has introduced new guidelines to enhance enforcement and collaboration with relevant departments [1][2][3]. Regulatory Actions - In the first half of 2025, a total of 1,666 illegal medical advertising cases were investigated, resulting in fines totaling 12.78 million yuan [1]. - The administration has publicly exposed 30 typical cases of illegal advertising across various sectors, including medical beauty and medical devices [1]. New Guidelines - Two new guidelines were introduced: the "Medical Advertising Regulatory Work Guidelines" and the "Medical Advertising Recognition Guidelines," aimed at clarifying the principles and rules for medical advertising regulation [2][3]. - The "Medical Advertising Regulatory Work Guidelines" provide detailed regulations for enforcement, including specific illegal advertising behaviors and responsibilities for internet platforms [2]. - The "Medical Advertising Recognition Guidelines" define what constitutes medical advertising and emphasize that only legally established medical institutions can publish such ads [3]. Collaborative Efforts - The administration has strengthened inter-departmental collaboration, enhancing the effectiveness of medical advertising regulation through joint enforcement and information sharing [5][6]. - Local market regulation departments are actively cooperating with industry authorities to improve the regulatory outcomes of medical advertising [5]. Future Directions - The administration plans to guide local departments in promoting compliance among medical institutions regarding advertising practices and to continue researching complex regulatory issues [6].